Diffuse follicle center lymphoma, intra-abdominal lymph nodes
ICD-10 C82.53 is a billable code used to indicate a diagnosis of diffuse follicle center lymphoma, intra-abdominal lymph nodes.
Diffuse follicle center lymphoma (DFCL) is a subtype of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells that arise from follicle center (germinal center) cells. This specific code, C82.53, indicates that the lymphoma is primarily located in the intra-abdominal lymph nodes. Clinically, patients may present with abdominal pain, swelling, or other gastrointestinal symptoms due to lymphadenopathy. DFCL is often associated with advanced disease at diagnosis, and patients may exhibit B-symptoms such as fever, night sweats, and weight loss. Staging of DFCL typically follows the Ann Arbor classification, which assesses the extent of lymph node involvement and the presence of systemic symptoms. Treatment protocols may include chemotherapy, immunotherapy, or targeted therapies, depending on the stage and individual patient factors. Accurate coding is essential for appropriate treatment planning and reimbursement.
Detailed clinical notes on diagnosis, staging, treatment plans, and follow-up.
Diagnosis and management of lymphoma, treatment response evaluation, and monitoring for recurrence.
Ensure accurate documentation of all symptoms and treatment modalities to support coding.
Histopathological reports confirming the diagnosis and subtype of lymphoma.
Review of biopsy specimens and correlation with clinical findings.
Pathology reports must clearly state the subtype and location of lymphoma for accurate coding.
Used during treatment of diffuse follicle center lymphoma.
Document the specific chemotherapy agent, dosage, and administration details.
Oncology specialists must ensure accurate coding of chemotherapy sessions.
Common symptoms include abdominal pain, swelling, fever, night sweats, and unexplained weight loss. Patients may also present with lymphadenopathy.
